Senate Bill Seeks to Speed Fast-Track Options for Opioid Alternatives

In the latest addition to the swirl of opioid-related bills circulating on Capitol Hill, four senators introduced legislation to require the FDA to issue guidance on how breakthrough and accelerated approval designations apply to novel, non-opioid or non-addictive pain medications.
Source: Drug Industry Daily